Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: Clinical and biological significance

Blood Cancer Journal

Volumn 3, Issue 7, 2013, Pages

  Kuo, S H ^a   Chen, L T ^b,c,d   Lin, C W ^a   Wu, M S ^a   Hsu, P N ^a   Tsai, H J ^b,c   Chu, C Y ^b   Tzeng, Y S ^a   Wang, H P ^a   Yeh, K H ^a   Cheng, A L ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antibiotics; CagA; MALT lymphoma; Stomach

Indexed keywords

CAGA PROTEIN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER PATIENT; CANCER REGRESSION; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA CELL; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 84880916132     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2013.22     Document Type: Article

References (45)

1. Du MQ, Isaacson PG. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol 2002; 3: 97-104.
2. Farinha P, Gascoyne RD. Helicobacter pylori and MALT lymphoma. Gastroenterology 2005; 128: 1579-1605. (Pubitemid 40692554)
3. Isaacson PG, Du MQ. Gastrointestinal lymphoma: where morphology meets molecular biology. J Pathol 2005; 205: 255-274. (Pubitemid 40227996)
4. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342: 571-574. (Pubitemid 23259232)
5. Hussell T, Isaacson PG, Crabtree JE, Dogan A, Spencer J. Immunoglobulin specificity of low grade B cell gastrointestinal lymphoma of mucosa associated lymphoid tissue (MALT) type. Am J Pathol 1993; 142: 285-292. (Pubitemid 23026931)
6. Greiner A, Marx A, Heesemann J, Leebmann J, Schmausser B, Müller-Hermelink HK. Idiotype identity in a MALT type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab Invest 1994; 70: 572-578. (Pubitemid 24185029)
7. Hussell T, Isaacson PG, Crabtree JE, Spencer J. Helicobacter pylori-specific tumourinfiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 1996; 178: 122-127.
8. Hauer AC, Finn TM, MacDonald TT, Spencer J, Isaacson PG. Analysis of TH1 and TH2 cytokine production in low-grade B-cell gastric MALT-type lymphomas stimulated in vitro with Helicobacter pylori. J Clin Pathol 1997; 50: 957-959. (Pubitemid 27524021)
9. Greiner A, Knorr C, Qin Y, Sebald W, Schimpl A, Banchereau J et al. Low-grade B-cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signalling and Th2-type cytokines for in vitro growth and differentiation. Am J Pathol 1997; 150: 1583-1593. (Pubitemid 27193808)
10. Mueller A, O'rouuke J, Chu P, Chu A, Dixon MF, Bouley DM et al. The role of antigenic drive and tumor-infiltrating accessory cells in the pathogenesis of Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Am J Pathol 2005; 167: 797-812. (Pubitemid 41216363)
11. de Jong D, Vyth-Dreese F, Dellemijn T, Verra N, Ruskoné- Fourmestraux A, Lavergne-Slove A et al. Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma. J Pathol 2001; 193: 318-324. (Pubitemid 32229862)
12. Kuo SH, Chen LT, Chen CL, Doong SL, Yeh KH, Wu MS et al. Expression of CD86 and increased infiltration of NK cells are associated with Helicobacter pyloridependent state of early stage high-grade gastric MALT lymphoma. World J Gastroenterol 2005; 11: 4357-4362.
13. Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002; 122: 1286-1294. (Pubitemid 34465171)
14. Du MQ, Atherton JC. Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management. Gut 2006; 55: 886-893. (Pubitemid 43764563)
15. Du MQ. MALT lymphoma: many roads lead to nuclear factor-kb activation. Histopathology 2011; 58: 26-38.
16. Ye H, Gong L, Liu H, Ruskone-Fourmestraux A, de Jong D, Pileri S et al. Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H. pylori eradication. Gut 2006; 55: 137-138.
17. Yeh KH, Kuo SH, Chen LT, Mao TL, Doong SL, Wu MS et al. Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21). Blood 2005; 106: 1037-1041.
18. Lin WC, Tsai HF, Kuo SH, Wu MS, Lin CW, Hsu PI et al. Translocation of Helicobacter pylori CagA into Human B lymphocytes, the origin of mucosaassociated lymphoid tissue lymphoma. Cancer Res 2010; 70: 5740-5748.
19. Franceschi F, Sepulveda AR, Gasbarrini A, Pola P, Silveri NG, Gasbarrini G et al. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 2002; 106: 430-434. (Pubitemid 34803686)
20. Mishima Y, Terui Y, Takeuchi K, Matsumoto-Mishima Y, Matsusaka S, Utsubo-Kuniyoshi R et al. The identification of irreversible rituximab-resistant lymphoma caused by CD20 gene mutations. Blood Cancer J 2011; 1: e15.
21. Kuo SH, Hsu CH, Chen LT, Lu YS, Lin CH, Yeh PY et al. Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells toward mTOR inhibitor, RAD001. Eur J Cancer 2011; 47: 1244-1257.
22. Roccaro AM, Sacco A, Husu EN, Pitsillides C, Vesole S, Azab AK et al. Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia. Blood 2010; 115: 559-569.
23. Leleu X, Jia X, Runnels J, Ngo HT, Moreau AS, Farag M et al. The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia. Blood 2007; 110: 4417-4426. (Pubitemid 351377808)
24. Gelebart P, Hegazy SA, Wang P, Bone KM, Anand M, Sharon D et al. Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma. Blood Cancer J 2012; 2: e82.
25. Chen LT, Lin JT, Tai JJ, Chen GH, Yeh HZ, Yang SS et al. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst 2005; 97: 1345-1353. (Pubitemid 41487802)
26. Ruskoné-Fourmestraux A, Fischbach W, Aleman BM, Boot H, Du MQ, Megraud F et al. on behalf of the EGILS group. EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 2011; 60: 747-758.
27. Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol 1990; 136: 1153-1164. (Pubitemid 20188502)
28. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-577. (Pubitemid 23259233)
29. Morgner A, Bayerdörffer E, Neubauer A, Stolte M. Helicobacter pylori associated gastric B cell MALT lymphoma: predictive factors for regression. Gut 2001; 48: 290-292. (Pubitemid 32269551)
30. Ruskoné-Fourmestraux A, Lavergne A, Aegerter PH, Megraud F, Palazzo L, de Mascarel A et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 2001; 48: 297-303. (Pubitemid 32269554)
31. Ghoshal UC, Tiwari S, Dhingra S, Pandey R, Ghoshal U, Tripathi S et al. Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: the Indian enigma. Dig Dis Sci 2008; 53: 1215-1222.
32. Achyut BR, Moorchung N, Srivastava AN, Gupta NK, Mittal B. Risk of lymphoid follicle development in patients with chronic antral gastritis: role of endoscopic features, histopathological parameters, CagA status and interleukin-1 gene polymorphisms. Inflamm Res 2008; 57: 51-56. (Pubitemid 351302057)
33. Peng H, Ranaldi R, Diss TC, Isaacson PG, Bearzi I, Pan L. High frequency of CagA+ Helicobacter pylori infection in high-grade gastric MALT B-cell lymphomas. J Pathol 1998; 185: 409-412. (Pubitemid 28355974)
34. Delchier JC, Lamarque D, Levy M, Tkoub EM, Copie-Bergman C, Deforges L et al. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type. Am J Gastroenterol 2001; 96: 2324-2328. (Pubitemid 32769190)
35. Eck M, Schmausser B, Haas R, Greiner A, Czub S, Müller-Hermelink HK. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 1997; 112: 1482-1486. (Pubitemid 27181371)
36. Sumida T, Kitadai Y, Hiyama T, Shinagawa K, Tanaka M, Kodama M et al. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma. Cancer Sci 2009; 100: 1075-1081.
37. Umehara S, Higashi H, Ohnishi N, Asaka M, Hatakeyama M. Effects of Helicobacter pylori CagA protein on the growth and survival of B lymphocytes, the origin of MALT lymphoma. Oncogene 2003; 22: 8337-8342. (Pubitemid 37485526)
38. Zhu Y, Wang C, Huang J, Ge Z, Dong Q, Zhong X et al. The Helicobacter pylori virulence factor CagA promotes Erk1/2-mediated Bad phosphorylation in lymphocytes: a mechanism of CagA-inhibited lymphocyte apoptosis. Cell Microbiol 2007; 9: 952-561.
39. Kuo SH, Chen LT, Lin CW, Wu mS, Hsu PN, Tasi HJ et al. Detection of CagA expression in gastric mucosa-associated lymphoid tissue lymphoma - biological significance and clinical implication. Ann Oncol 2012; 23(Suppl 9): ix351.
40. Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA 2008; 105: 1003-1008. (Pubitemid 351282071)
41. Qu CK, Nguyen S, Chen J, Feng GS. Requirement of Shp-2 tyrosine pohosphatase in lymphoid and hematopoietic cell development. Blood 2001; 97: 911-914. (Pubitemid 32154273)
42. D'Elios MM, Amedei A, Manghetti M, Costa F, Baldari CT, Quazi AS et al. Impaired T-cell regulation of B-cell growth in Helicobacter pylori-related gastric low-grade MALT lymphoma. Gastroenterology 1999; 117: 1105-1112. (Pubitemid 29512669)
43. Lundgren A, Stromberg E, Sjoling A, Lindholm C, Enarsson K, Edebo A et al. Mucosal FOXP3-expressing CD4+CD25 high regulatory T cells in Helicobacter pylori-infected patients. Infect Immun 2005; 73: 523-531. (Pubitemid 40041147)
44. Rad R, Brenner L, Bauer S, Schwendy S, Layland L, da Costa CP et al. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 2006; 131: 525-537. (Pubitemid 44142446)
45. Craig VJ, Cogliatti SB, Arnold I, Gerke C, Balandat JE, Wündisch T et al. B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis. Leukemia 2010; 24: 1186-1196.